These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 23719722)

  • 21. Intranasal interferon beta improves memory and modulates inflammatory responses in a mutant APP-overexpressing rat model of Alzheimer's disease.
    Chavoshinezhad S; Mohseni Kouchesfahani H; Salehi MS; Pandamooz S; Ahmadiani A; Dargahi L
    Brain Res Bull; 2019 Aug; 150():297-306. PubMed ID: 31233762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intranasal administration of insulin lowers amyloid-beta levels in rat model of diabetes.
    Subramanian S; John M
    Indian J Exp Biol; 2012 Jan; 50(1):41-4. PubMed ID: 22279939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma rich in growth factors (PRGF-Endoret) reduces neuropathologic hallmarks and improves cognitive functions in an Alzheimer's disease mouse model.
    Anitua E; Pascual C; Antequera D; Bolos M; Padilla S; Orive G; Carro E
    Neurobiol Aging; 2014 Jul; 35(7):1582-95. PubMed ID: 24524966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
    Claxton A; Baker LD; Hanson A; Trittschuh EH; Cholerton B; Morgan A; Callaghan M; Arbuckle M; Behl C; Craft S
    J Alzheimers Dis; 2015; 44(3):897-906. PubMed ID: 25374101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease.
    Rosenbloom MH; Barclay TR; Pyle M; Owens BL; Cagan AB; Anderson CP; Frey WH; Hanson LR
    CNS Drugs; 2014 Dec; 28(12):1185-9. PubMed ID: 25373630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
    Talbot K; Wang HY; Kazi H; Han LY; Bakshi KP; Stucky A; Fuino RL; Kawaguchi KR; Samoyedny AJ; Wilson RS; Arvanitakis Z; Schneider JA; Wolf BA; Bennett DA; Trojanowski JQ; Arnold SE
    J Clin Invest; 2012 Apr; 122(4):1316-38. PubMed ID: 22476197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interlink Between Insulin Resistance and Neurodegeneration with an Update on Current Therapeutic Approaches.
    Bhattamisra SK; Shin LY; Saad HIBM; Rao V; Candasamy M; Pandey M; Choudhury H
    CNS Neurol Disord Drug Targets; 2020; 19(3):174-183. PubMed ID: 32418534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Mechanisms of Intranasal Insulin in SAMP8 Mice.
    Rhea EM; Nirkhe S; Nguyen S; Pemberton S; Bammler TK; Beyer R; Niehoff ML; Morley JE; Farr SA; Banks WA
    J Alzheimers Dis; 2019; 71(4):1361-1373. PubMed ID: 31561374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin mediated novel therapies for the treatment of Alzheimer's disease.
    Dubey SK; Lakshmi KK; Krishna KV; Agrawal M; Singhvi G; Saha RN; Saraf S; Saraf S; Shukla R; Alexander A
    Life Sci; 2020 May; 249():117540. PubMed ID: 32165212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.
    Reger MA; Watson GS; Frey WH; Baker LD; Cholerton B; Keeling ML; Belongia DA; Fishel MA; Plymate SR; Schellenberg GD; Cherrier MM; Craft S
    Neurobiol Aging; 2006 Mar; 27(3):451-8. PubMed ID: 15964100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The brain as an insulin-sensitive metabolic organ.
    Milstein JL; Ferris HA
    Mol Metab; 2021 Oct; 52():101234. PubMed ID: 33845179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease.
    Barone E; Tramutola A; Triani F; Calcagnini S; Di Domenico F; Ripoli C; Gaetani S; Grassi C; Butterfield DA; Cassano T; Perluigi M
    Mol Neurobiol; 2019 Apr; 56(4):2922-2943. PubMed ID: 30073505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin: an emerging treatment for Alzheimer's disease dementia?
    Morris JK; Burns JM
    Curr Neurol Neurosci Rep; 2012 Oct; 12(5):520-7. PubMed ID: 22791280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease.
    Stein MS; Scherer SC; Ladd KS; Harrison LC
    J Alzheimers Dis; 2011; 26(3):477-84. PubMed ID: 21694461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intranasal insulin on cognitive function: a systematic review.
    Shemesh E; Rudich A; Harman-Boehm I; Cukierman-Yaffe T
    J Clin Endocrinol Metab; 2012 Feb; 97(2):366-76. PubMed ID: 22162476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First clinical data of the neuroprotective effects of nasal insulin application in patients with Alzheimer's disease.
    Hölscher C
    Alzheimers Dement; 2014 Feb; 10(1 Suppl):S33-7. PubMed ID: 24529523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.
    Shi Y; Zhang L; Gao X; Zhang J; Ben Abou M; Liang G; Meng Q; Hepner A; Eckenhoff MF; Wei H
    J Alzheimers Dis; 2020; 76(4):1375-1389. PubMed ID: 32623395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease.
    Ettcheto M; Sánchez-López E; Gómez-Mínguez Y; Cabrera H; Busquets O; Beas-Zarate C; García ML; Carro E; Casadesus G; Auladell C; Vázquez Carrera M; Folch J; Camins A
    Mol Neurobiol; 2018 Sep; 55(9):7327-7339. PubMed ID: 29404958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Insulin Signaling for the Treatment of Alzheimer's Disease.
    Chen Y; Zhang J; Zhang B; Gong CX
    Curr Top Med Chem; 2016; 16(5):485-92. PubMed ID: 26268336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.